Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Some Lupus Tests Yield False Results

Staff  |  Issue: June 2007  |  June 1, 2007

The ACR’s Regional Advisory Council (RAC) has received several member reports of false results on antinuclear antibody (ANA) tests. The test screens for systemic lupus erythematosus, drug-induced lupus, and other diseases. Results are used to direct treatment, so accuracy is crucial.

RAC member John Goldman, MD, investigated the issue to help ACR members obtain accurate test results. Indirect Fluorescent Antibody (IFA) is the gold standard for ANA testing. Quest Diagnostics generally screens ANA tests with ELISA and, if the result is positive, reflexes to IFA. However, physicians can request an IFA by ordering 249X and adding “Force Reflex” to the order.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

LabCorp screens ANA tests with Athena Beads. The Athena Bead test has different colored beads, each one coated with different ANA subsets: SSA, SSB, Sm, RNP, Scl-70, Jo-1, Centromere B, dsDNA, and Histone. The test is positive if any of the subsets are over 100. Physicians may request IFA by ordering 164947.

Dr. Goldman reviewed the literature and determined that Athena Beads and ELISA ANA testing are somewhat comparable, but neither is as reliable as IFA. The RAC wants to make sure ACR members have the information necessary to make appropriate decisions for their practices. If you have additional questions or concerns, contact ACR coding specialists Melesia Tillman, CPC, or Resaee Freeman, CPC, via e-mail at [email protected] or [email protected], respectively, or by phone at (404) 633-3777.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:From the College Tagged with:AC&Rantinuclear antibodiesLupusRegional Advisory CouncilTest

Related Articles

    Medicare Bills Under the Magnifying Glass

    December 1, 2009

    What you need to know about the Recovery Audit Contractor program

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    New Study Reveals Limitations in ANA Test Kits for Lupus

    September 20, 2018

    The variability in serological testing for antinuclear antibodies (ANA) is under investigation after unexpected findings were reported from clinical trials of new agents to treat systemic lupus erythematosus (SLE). In “Assay Variation in the Detection of Antinuclear Antibodies in the Sera of Patients with Established SLE,” David S. Pisetsky, MD, PhD, and his colleagues demonstrate…

    Know Your Labs

    February 1, 2009

    A review of state-of-the-art testing for SLE and connective tissue disease.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences